• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI INTECC CO., LTD. TORNUS; PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI INTECC CO., LTD. TORNUS; PERCUTANEOUS CATHETER Back to Search Results
Device Problem Difficult to Remove (1528)
Patient Problem Insufficient Information (4580)
Event Type  Injury  
Event Description
It was reported through the literature that asahi tornus penetration catheter was difficult to be removed and required surgical intervention.Details are as follows: publication: journal of invasive cardiology (https://www.Hmpgloballearningnetwork.Com/site/jic/articles/frequency-treatment-and-consequences-device-loss-and-entrapment-contemporary-percutaneous-c) title: frequency, treatment, and consequences of device loss and entrapment in contemporary percutaneous coronary interventions.[methods] we reviewed 2338 consecutive pci cases performed between 1/2005 and 5/2010 at our institution to identify cases of device loss or entrapment.The angiograms and outcomes of these patients were reviewed.[device entrapment] in contrast to device loss, 3 of 4 patients (75%) with device entrapment required emergency surgical removal and coronary artery bypass grafting.The entrapped devices were coronary guidewires (n = 2), a filterwire (boston scientific), and a tornus catheter (abbott vascular).In the fourth patient, a tornus catheter (abbott vascular) became entrapped during attempts to cross a mid right coronary artery chronic total occlusion.Attempts to advance a second guidewire next to the entrapped catheter failed and the patient required surgical removal of the catheter and coronary artery bypass grafting, followed by an uneventful recovery.
 
Manufacturer Narrative
Manufacturing site: manufacturing site could not be identified because the product lot number information was not available.Device evaluation could not be performed because the affected device was not returned from the user facility.Lot history records review could not be conducted because lot information was unavailable.All the shipped products were inspected in the production process and satisfied the product specifications and release criteria; therefore, it was concluded that there was no anomaly in product quality.According to the literature, removal difficulty was due to the lesion; the catheter was caught by the lesion.It was concluded that this event was associated with lesion and procedural properties, not related to product quality.No capa will be taken.Instructions for use (ifu) states: [warnings] if any resistance or something abnormal is felt when operating this catheter, do not continue the operation while the causes are unclear.If it is suspected that the product is not operating correctly, avoid excessive manipulations, and carefully remove the entire catheter system while paying full attention to avoid complications.If there are complications as a result of the removal of the entire system, stop immediately the percutaneous transluminal coronary angioplasty (ptca) or the percutaneous transluminal angioplasty (pta), and perform appropriate treatment at the discretion of the physician.(continuing the operation while the cause of the problem is not identified may cause damage to or breakage of the catheter, and damage the blood vessel.In the worst case, life-threatening adverse events may result.) if a strong reaction is felt in the opposite direction of rotation when the catheter is advanced toward or withdrawn from the lesion, the catheter may be caught.Operate the catheter carefully and do not forcefully continue the procedure.(it may damage or break the catheter or damage the blood vessels.In the worst case, life-threatening adverse events may result.) [malfunction and adverse events] removal difficulty.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TORNUS
Type of Device
PERCUTANEOUS CATHETER
Manufacturer (Section D)
ASAHI INTECC CO., LTD.
3-100 akatsuki-cho
seto, aichi 489-0 071
JA  489-0071
Manufacturer (Section G)
ASAHI INTECC CO., LTD.
3-100 akatsuki-cho
seto, aichi 489-0 071
JA   489-0071
Manufacturer Contact
yukako homma
3-100 akatsuki-cho
seto, aichi 489-0-071
JA   489-0071
MDR Report Key16011065
MDR Text Key305775293
Report Number3003775027-2022-00165
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K051772
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/30/2022
Initial Date FDA Received12/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-